Breaking News

Dr. Kevin Williams

Dr. Kevin Williams Issues Caution to African Americans About Rare Heart Disease
FamilyHealth

Dr. Kevin Williams Issues Caution to African Americans About Rare Heart Disease

Stacy M. Brown NNPA Newswire Senior National CorrespondentMay 27, 2021

With the most recent collaboration between Pfizer Rare Disease and the Black Press, the organizations embarked on a mission to educate and raise awareness to transthyretin amyloid cardiomyopathy – or ATTR-CM. “ATTR-CM is a rare, life-threatening, underrecognized, and underdiagnosed type of amyloidosis that affects the heart and it is associated with heart failure,” Dr. Kevin Williams, Pfizer’s chief medical officer, told the NNPA in a live interview.

Pfizer, AmeriHealth Caritas Officials Talk Health at NNPA Conference
HealthNationalNews

Pfizer, AmeriHealth Caritas Officials Talk Health at NNPA Conference

Stacy M. Brown, NNPA Newswire Senior CorrespondentJanuary 30, 2020

Dr. Kevin Williams, the chief medical officer for Pfizer Rare Disease, addressed the conference during a Pfizer-hosted breakfast presentation titled, “African Americans and Heart Disease – New Research Breakthrough: Announcing 2020 Partnership between Pfizer and NNPA.” At a later session titled “Future of Medicaid and Medicare: Healthy You, Healthy Us – What is Managed Care and How Does It Advance Health Equity,” AmeriHealth Caritas officials said it was important to gain a greater understanding of the different ways managed care organizations address key social disparities.